![]() |
|
"Mitocans as Novel Agents for Anticancer Therapy: An Overview"
written by Anatole A. Klyosov, Igor L. Rozhanskii,
published by International Journal of Clinical Medicine, Vol.2 No.4, 2011
has been cited by the following article(s):
[1]
Mitochondrial permeability transition as target of anticancer drugs
Current pharmaceutical design
2014
[2]
First Spin-Labeled α-Tocopherol and Trolox Succinyl Derivatives
Chemistry of Natural Compounds
2014
[3]
Conjugates of Natural Compounds with Nitroxyl Radicals as a Basis for Creation of Pharmacological Agents of New Generation
Current medicinal chemistry
2014
[4]
Rhodamine B conjugates of triterpenoic acids are cytotoxic mitocans even at nanomolar concentrations
European Journal of Medicinal Chemistry
2017
[5]
TRITERPEN-CARBONSÄURE-DERIVATEN
Dissertation
2017
[6]
Mitochondria-localizing BODIPY–copper (ii) conjugates for cellular imaging and photo-activated cytotoxicity forming singlet oxygen
Dalton Transactions
2018
[7]
Targeting mitochondria: Esters of rhodamine B with triterpenoids are mitocanic triggers of apoptosis
European Journal of Medicinal Chemistry
2018
[8]
An X-ray and Natural Bond Orbital (NBO) structural study of α-tocopheryl and 2, 2, 5, 7, 8-pentamethylchroman-6-yl succinates
Journal of Saudi Chemical Society
2018
[9]
Guanidine-Based DNA Binders and Strategies Toward their Platinum Complexes as Anticancer Dual Agents
2016
[10]
Synthese und biologische Evaluierung von Triterpen-Carbonsäure-Derivaten
2017
[11]
Mitochondria-Targeting Anticancer Metal Complexes
2018
[12]
Targeting Mitochondria Through the Use of Mitocans as Emerging Anticancer Agents
2019